Aim: To investigate the usefulness of some clinical and laboratory parameters in assessing the prognosis and survival of CLL in a resource-limited setting. Methods : Between September 1986 and March 2007, 79 consecutive patients were retrospectively studied. Diagnosis was based on clinical and haematological findings. Results : A total of 79 patients, aged 30 to 81 (median = 60) years were managed. There were 34 males and 45 females (ratio = 0.8:1). About 86.1% were aged above 50 years. Massive splenomegaly and hepatomegaly were recorded in 70.9% and 29.1% of patients, respectively. More than 63% presented in stage C. Anaemia was recorded in 74.7%. Haematocrit correlated negatively with WBC but positively with platelet count. The spleen cor...
CONTEXT: Chronic lymphocytic leukemia (CLL) is a clonal lymphoproliferative disorder, characterized ...
Background & Aims. B-cellular chronic lymphocytic leukemia (CLL) is a disease with heterogeneous cli...
n the past 20 years important progress has been made in the understanding of chronic lymphoprolifera...
Aim: To investigate the usefulness of some clinical and laboratory parameters in assessing the progn...
A retrospective analysis of all patients that were diagnosed and managed for Chronic lymphocytic Leu...
BackgroundChronic lymphocytic leukaemia is a relatively common haematological malignancy affecting o...
Chronic lymphocytic leukaemia (CLL) is a disease of late middle age and older. The majority of patie...
Clinical and biological data were evaluated using Desu univariate analyses or Cox multivariate analy...
ABSTRACT Introduction: Chronic myeloid leukaemia (CML) is a clonal haematological condition charact...
Objective: To characterize the immunophenotypic features of CLL/SLL among patients diagnosed at Aga ...
Chronic lymphocytic leukemia (CLL) is the most common lymphoproliferative disorder in the West accou...
Chronic lymphocytic leukaemia remains the most common adult leukaemia in Western countries. In this ...
Chronic lymphocytic leukaemia (CLL) is rare locally. Seven CLL patients which constituted 0.9 % of t...
Chronic lymphocytic leukaemia (CLL) is the most common form of leukaemia among the elderly in the de...
<p><strong>Introduction.</strong> Chronic lymphoproliferative disease (CLPD) are common hematologic ...
CONTEXT: Chronic lymphocytic leukemia (CLL) is a clonal lymphoproliferative disorder, characterized ...
Background & Aims. B-cellular chronic lymphocytic leukemia (CLL) is a disease with heterogeneous cli...
n the past 20 years important progress has been made in the understanding of chronic lymphoprolifera...
Aim: To investigate the usefulness of some clinical and laboratory parameters in assessing the progn...
A retrospective analysis of all patients that were diagnosed and managed for Chronic lymphocytic Leu...
BackgroundChronic lymphocytic leukaemia is a relatively common haematological malignancy affecting o...
Chronic lymphocytic leukaemia (CLL) is a disease of late middle age and older. The majority of patie...
Clinical and biological data were evaluated using Desu univariate analyses or Cox multivariate analy...
ABSTRACT Introduction: Chronic myeloid leukaemia (CML) is a clonal haematological condition charact...
Objective: To characterize the immunophenotypic features of CLL/SLL among patients diagnosed at Aga ...
Chronic lymphocytic leukemia (CLL) is the most common lymphoproliferative disorder in the West accou...
Chronic lymphocytic leukaemia remains the most common adult leukaemia in Western countries. In this ...
Chronic lymphocytic leukaemia (CLL) is rare locally. Seven CLL patients which constituted 0.9 % of t...
Chronic lymphocytic leukaemia (CLL) is the most common form of leukaemia among the elderly in the de...
<p><strong>Introduction.</strong> Chronic lymphoproliferative disease (CLPD) are common hematologic ...
CONTEXT: Chronic lymphocytic leukemia (CLL) is a clonal lymphoproliferative disorder, characterized ...
Background & Aims. B-cellular chronic lymphocytic leukemia (CLL) is a disease with heterogeneous cli...
n the past 20 years important progress has been made in the understanding of chronic lymphoprolifera...